Protein kinases are important targets for designing therapeutic drugs. This
paper illustrates a computational approach to extend the usefulness of a s
ingle protein-inhibitor structure in aiding the design of protein kinase in
hibitors. Using the complex structure of the catalytic subunit of PKA (cPKA
) and balanol as a guide, we have analyzed and compared the distribution of
amino acid types near the protein-ligand interface for nearly 400 kinases.
This analysis has identified a number of sites that are more variable in a
mino acid types among the kinases analyzed, and these are useful sites to c
onsider in designing specific protein kinase inhibitors. On the other hand,
we have found kinases whose protein-ligand interfaces are similar to that
of the cPKA-balanol complex and balanol can be a useful lead compound for d
eveloping effective inhibitors for these kinases. Generally, this approach
can help us discover new drug targets for an existing class of compounds th
at have already been well characterized pharmacologically. The relative sig
nificance of the charge/polarity of residues at the protein-ligand interfac
e has been quantified by carrying out computational sensitivity analysis in
which the charge/polarity of an atom or functional group was turned off/on
, and the resulting effects on binding affinity have been examined. The bin
ding affinity was estimated by using an implicit-solvent model in which the
electrostatic contributions were obtained by solving the Poisson equation
and the hydrophobic effects were accounted for by using surface-area depend
ent terms. The same sensitivity analysis approach was applied to the ligand
balanol to develop a pharmacophoric model for searching new drug leads fro
m small-molecule libraries. To help evaluate the binding affinity of design
ed inhibitors before they are made, we have developed a semiempirical appro
ach to improve the predictive reliability of the implicit-solvent binding m
odel.